PerkinElmer acquires microarray company spectral genomics.
According to PerkinElmer, array-based karyotyping is expected to replace microscope-based Fluorescent In-Situ Hybridization (FISH) techniques for chromosome analysis. Spectral Genomics' SpectralChip is a nucleic acid array designed for comparative genomic hybridization applications. This technology fits well with PerkinElmer's focus on personalized medicine and new technologies for diagnostics.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Executive Briefing: News, Trends & Market Intelligence for Instrument Executives|
|Publication:||Instrument Business Outlook|
|Date:||May 15, 2006|
|Previous Article:||Thermo buys Fisher Scientific for $10.6 billion.|
|Next Article:||QIAGEN buys nucleic acid purification provider.|